Overview

Definition:
-Neonatal cholestasis is a clinical syndrome characterized by impaired bile flow from the liver to the duodenum, leading to a buildup of bilirubin and other bile constituents in the blood and tissues
-It is defined by conjugated hyperbilirubinemia (serum direct bilirubin > 1 mg/dL if total bilirubin > 5 mg/dL, or > 20% of total bilirubin).
Epidemiology:
-The incidence of neonatal cholestasis is approximately 1 in 2,500 live births, with a higher prevalence in premature infants
-Biliary atresia is the most common indication for liver transplantation in children and accounts for about one-third of neonatal cholestasis cases.
Clinical Significance:
-Early recognition and prompt management of neonatal cholestasis are crucial to prevent irreversible liver damage, liver failure, and death
-Delay in diagnosis, particularly in conditions like biliary atresia, significantly impacts the success of surgical interventions and long-term outcomes.

Clinical Presentation

Symptoms:
-Jaundice appearing after 2 weeks of life
-Dark urine leading to staining of diapers
-Pale or acholic stools
-Poor weight gain and failure to thrive
-Irritability or lethargy
-Vomiting
-Abdominal distension.
Signs:
-Prolonged conjugated jaundice
-Pale or white stools (acholic)
-Dark urine
-Hepatomegaly
-Splenomegaly may be present in later stages
-Signs of malabsorption such as steatorrhea.
Diagnostic Criteria:
-Diagnosis is confirmed by laboratory evidence of conjugated hyperbilirubinemia (serum direct bilirubin > 1 mg/dL or > 20% of total bilirubin)
-Clinical suspicion is raised by prolonged jaundice and pale stools
-A universally accepted stool color chart aids in objective assessment.

Diagnostic Approach

History Taking:
-Detailed birth history: gestational age, mode of delivery, any perinatal insults
-Feeding history: type of milk, volume, suckling
-Maternal history: infections during pregnancy, medications
-Family history of liver or metabolic diseases
-Onset and progression of jaundice
-Urine color and stool color observations.
Physical Examination:
-Thorough physical examination focusing on the abdomen
-Palpate for hepatomegaly and splenomegaly
-Assess for ascites or abdominal masses
-Examine for dysmorphic features suggestive of genetic syndromes
-Assess hydration status and overall well-being.
Investigations:
-Initial investigations include complete blood count, liver function tests (ALT, AST, GGT, ALP, Total and Direct Bilirubin), coagulation profile (PT, INR), and urine analysis
-Ultrasound abdomen is crucial to assess liver and gallbladder morphology, biliary tree patency
-TORCH screening, metabolic workup (e.g., galactosemia, tyrosinemia, alpha-1 antitrypsin deficiency), and sometimes a liver biopsy may be required
-Consider stool color assessment using a standardized chart.
Differential Diagnosis:
-Includes infective causes (sepsis, viral hepatitis), metabolic disorders (galactosemia, tyrosinemia), genetic syndromes (Down syndrome, Alagille syndrome), endocrine disorders (hypothyroidism), parenteral nutrition-associated cholestasis, and structural abnormalities of the biliary system (biliary atresia, choledochal cyst)
-Congenital intrahepatic shunts also need consideration.

Stool Color Assessment

Importance:
-Objective assessment of stool color is vital for early detection of cholestasis
-Normal infant stools vary in color from yellow to green or brown
-Pale or acholic stools (white, clay-colored, or chalky) are a hallmark of cholestasis.
Stool Color Chart:
-A standardized stool color chart (e.g., the Japanese or Hong Kong stool color chart) should be used
-Parents are educated to compare their infant's stool color to the chart
-A color from 1-3 (on most charts) indicates pale stools and requires immediate medical attention.
Parental Education:
-Educating parents about normal stool color and the significance of pale stools is a critical public health measure
-This empowers them to seek timely medical help, thus facilitating early referral and intervention.

Early Referral And Management

Timing Is Key:
-Prompt referral to a pediatrician or a pediatric gastroenterologist is paramount
-For suspected biliary atresia, referral within the first 6-8 weeks of life offers the best chance for successful portoenterostomy (Kasai procedure).
Initial Management:
-Once diagnosed, management focuses on addressing the underlying cause
-For biliary atresia, surgical intervention (Kasai procedure) is time-sensitive
-For other causes, specific medical or surgical treatments are initiated.
Nutritional Support:
-Infants with cholestasis often have malabsorption of fat-soluble vitamins (A, D, E, K) and require specialized nutritional support
-Medium-chain triglyceride (MCT) based formulas and supplementation of fat-soluble vitamins are essential
-Adequate caloric intake is crucial for growth.
Follow Up:
-Close monitoring of liver function tests, growth parameters, and nutritional status is essential
-Long-term follow-up may be required, and some infants may eventually need liver transplantation.

Key Points

Exam Focus:
-Understand the definition of conjugated hyperbilirubinemia
-Recognize the importance of pale stools and the use of stool color charts
-Differentiate common causes of neonatal cholestasis, with emphasis on biliary atresia.
Clinical Pearls:
-Always ask parents about stool color if a newborn has prolonged jaundice
-Educate parents about the stool color chart at well-baby visits
-Biliary atresia is a surgical emergency
-timely referral dramatically improves prognosis
-GGT is a sensitive marker for cholestasis.
Common Mistakes:
-Misinterpreting prolonged jaundice as physiological
-Delaying referral for pale stools
-Inadequate nutritional management
-Failing to perform a timely ultrasound or consider a liver biopsy when indicated.